Analyst Reco. Shockwave Medical

Equities

SWAV

US82489T1043

Delayed Nyse Other stock markets 01:29:52 31/05/2024 am IST			5-day change	1st Jan Change
334.8 ^USD	-0.01%		+0.01%	+75.69%

03/06	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 1000	CI
03/06	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 400 Health Care	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368	09/04	MT
Leerink Partners Downgrades ShockWave Medical to Market Perform From Outperform, Cuts Price Target to $335 From $361	08/04	MT
Deutsche Bank Downgrades ShockWave Medical to Hold From Buy, Raises Price Target to $335 From $270	08/04	MT
Morgan Stanley Downgrades ShockWave Medical to Equal Weight From Overweight, Raises Price Target to $335 From $285	08/04	MT
Wolfe Research Downgrades ShockWave Medical to Peer Perform From Outperform	05/04	MT
Needham Downgrades ShockWave Medical to Hold From Buy	05/04	MT
Piper Sandler Raises Price Target on ShockWave Medical to $360 From $290, Keeps Overweight Rating	02/04	MT
CL King Initiates ShockWave Medical With Buy Rating, Price Target is $368	27/03	MT
UBS Raises Price Target on ShockWave Medical to $250 From $228, Maintains Neutral Rating	20/02	MT
Piper Sandler Raises ShockWave Medical's Price Target to $290 From $275, Keeps Overweight Rating	16/02	MT
Needham Adjusts Price Target on ShockWave Medical to $286 From $260, Keeps Buy Rating	16/02	MT
Morgan Stanley Raises Price Target on ShockWave Medical to $285 From $223, Keeps Overweight Rating	16/02	MT
Morgan Stanley Cuts ShockWave Medical's Price Target to $223 From $284, Maintains Overweight Rating	04/12	MT
Deutsche Bank Cuts ShockWave Medical Price Target to $270 From $310, Maintains Buy Rating	07/11	MT
Piper Sandler Adjusts ShockWave Medical Price Target to $275 From $315, Maintains Overweight Rating	07/11	MT
Needham Cuts Price Target on ShockWave Medical to $260 From $265, Maintains Buy Rating	07/11	MT
Morgan Stanley Cuts Price Target on ShockWave Medical to $284 From $313, Notes 'Peripheral Softness,' Keeps Overweight Rating	07/11	MT
UBS Adjusts ShockWave Medical Price Target to $226 From $218, Maintains Neutral Rating	24/23/24	MT
Needham Lowers ShockWave Medical's PT to $265 From $330 Due to Peer Multiple Contraction, Keeps Buy Rating	24/23/24	MT
BofA Slashes Price Target on ShockWave Medical to $250 From $316, Keeps Buy Rating	18/23/18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Shockwave Medical

Equities

SWAV

US82489T1043

Analyst Reco.

Filters